Abstract
AbstractThere is a compelling demand for approved plague vaccines due to the endemicity of Yersinia pestis and its potential for pandemic spread. Whilst substantial progress has been made, we recommend that the global funding and health security systems should work urgently to translate some of the efficacious vaccines reviewed herein to expedite clinical development and to prevent future disastrous plague outbreaks, particularly caused by antimicrobial resistant Y. pestis strains.Content includes material subject to Crown Copyright © 2024.This is an open access article under the Open Government License (http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/).
Publisher
Springer Science and Business Media LLC
Reference147 articles.
1. Brubaker, B. Factors promoting acute and chronic diseases caused by yersiniae. Clin. Microbiol Rev. 4, 309–324 (1991).
2. Pollitzer, R. Plague. World Health Organ Monogr. Ser. 22, 1–698 (1954).
3. Global consultation on Plague Vaccines, WHO https://www.who.int/news-room/events/detail/2023/10/12/default-calendar/global-consultation-on-plague-vaccines (2023).
4. Doll, J. M. et al. Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. Am. J. Trop. Med. Hyg. 5, 109–114 (1994).
5. Perry, R. D. & Fetherston, J. D. Yersinia pestis—etiologic agent of plague. Clin. Microbiol Rev. 10, 35–66 (1997).